Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-03

Clinical Trial Update: Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics [Phase 1, Phase 2]

View source ↗

Summary

A crossover Phase 1/2 trial comparing inhaled AQ001S to a budesonide suspension in adults with mild asthma has completed, with results posted. The update confir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AQ001S (AQ001S)
  • budesonide suspension (budesonide)

Snippet

Sponsor: Aquilon Pharmaceuticals S.A. | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-09-03